From: Age is associated with prognosis in serous ovarian carcinoma
Variable | Progression-free survival (OR, 95% CI) | Overall survival (OR, 95% CI) | ||
---|---|---|---|---|
Age | 1.02 | 1.00–1.02 | 1.02 | 1.00–1.02 |
FIGO stage | 1.33 | 1.12–1.63 | 1.49 | 1.29–1.75 |
Grade | 1.61 | 1.10–2.59 | 1.88 | 1.35–2.90 |
Baseline CA-125 | 1.00 | 1.00–1.02 | 1.01 | 1.00–1.01 |
Surgery outcome | ||||
 Optimal | 1.00 | (reference) | 1.00 | (reference) |
 Suboptimal | 1.25 | 1.08–1.51 | 1.58 | 1.29–1.85 |
Ascites | ||||
  < 500 mL | 1.00 | (reference) | 1.00 | (reference) |
  ≥ 500 mL | 1.04 | 0.75–2.05 | 1.05 | 0.59–2.72 |
NAC | ||||
 Yes | 1.00 | (reference) | 1.00 | (reference) |
 No | 1.02 | 0.79–1.54 | 1.03 | 0.73–1.82 |